Extendicare Inc.

DB:5XE Stock Report

Market Cap: €573.9m

Extendicare Management

Management criteria checks 4/4

Extendicare's CEO is Michael Guerriere, appointed in Oct 2018, has a tenure of 6.17 years. total yearly compensation is CA$1.81M, comprised of 33.1% salary and 66.9% bonuses, including company stock and options. directly owns 0.31% of the company’s shares, worth €1.78M. The average tenure of the management team and the board of directors is 2.3 years and 8 years respectively.

Key information

Michael Guerriere

Chief executive officer

CA$1.8m

Total compensation

CEO salary percentage33.1%
CEO tenure6.2yrs
CEO ownership0.3%
Management average tenure2.3yrs
Board average tenure8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Michael Guerriere's remuneration changed compared to Extendicare's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

CA$64m

Jun 30 2024n/an/a

CA$59m

Mar 31 2024n/an/a

CA$35m

Dec 31 2023CA$2mCA$600k

CA$34m

Sep 30 2023n/an/a

CA$18m

Jun 30 2023n/an/a

CA$1m

Mar 31 2023n/an/a

CA$3m

Dec 31 2022CA$2mCA$600k

-CA$5m

Sep 30 2022n/an/a

-CA$1m

Jun 30 2022n/an/a

CA$6m

Mar 31 2022n/an/a

CA$4m

Dec 31 2021CA$2mCA$600k

CA$8m

Sep 30 2021n/an/a

CA$27m

Jun 30 2021n/an/a

CA$59m

Mar 31 2021n/an/a

CA$49m

Dec 31 2020CA$2mCA$600k

CA$42m

Sep 30 2020n/an/a

CA$31m

Jun 30 2020n/an/a

CA$2m

Mar 31 2020n/an/a

CA$15m

Dec 31 2019CA$2mCA$600k

CA$15m

Sep 30 2019n/an/a

CA$1m

Jun 30 2019n/an/a

CA$4m

Mar 31 2019n/an/a

CA$6m

Dec 31 2018CA$829kCA$118k

CA$8m

Compensation vs Market: Michael's total compensation ($USD1.26M) is about average for companies of similar size in the German market ($USD1.01M).

Compensation vs Earnings: Michael's compensation has been consistent with company performance over the past year.

CEO

Michael Guerriere (60 yo)

6.2yrs

Tenure

CA$1,814,755

Compensation

Dr. Michael R. Guerriere, MD, MBA, has been the Chief Executive Officer and President at Extendicare Inc. since joined in October 22, 2018. Dr. Guerriere serves as Chairman and Chief Executive Officer of E...

Leadership Team

NamePositionTenureCompensationOwnership
Michael Guerriere
CEO, President & Director6.2yrsCA$1.81m0.31%
€ 1.8m
David Bacon
Senior VP & CFO5.7yrsCA$1.12m0.15%
€ 881.6k
Steve Paraskevopoulos
Senior Vice President of ParaMed & CTO2.3yrsCA$738.35k0.052%
€ 299.1k
John Toffoletto
Senior VP5.1yrsCA$966.91k0.069%
€ 393.5k
Matthew Morgan
Chief Medical Officer4.2yrsCA$655.99k0.13%
€ 757.2k
Joe Belinsky
VP of Information Technology & Chief Information Officerless than a yearno datano data
Jillian Fountain
Vice President of Investor Relations6.6yrsCA$364.43k0.054%
€ 310.1k
Danielle Parr
Vice President of Public Affairsless than a yearno datano data
Kathryn Bradley
Vice President of Corporate Development1.9yrsno data0.014%
€ 83.0k
Katie LeMoyne
Senior VP & Chief Human Resources Officer1.9yrsno data0.027%
€ 154.7k
Wendy Gilmour
Senior Vice President of Long-term Care Operations1.9yrsno datano data
Amie Vahrmeyer
Vice President of Long-Term Care Operations for ONno datano datano data

2.3yrs

Average Tenure

Experienced Management: 5XE's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Michael Guerriere
CEO, President & Director6.8yrsCA$1.81m0.31%
€ 1.8m
Alan Torrie
Independent Chairman of the Board8.9yrsCA$210.00k0.042%
€ 240.6k
Alvin Libin
Honorary Director8.9yrsCA$123.37kno data
Seth Goldsmith
Honorary Director8.9yrsCA$177.37kno data
Samir Manji
Independent Director5.6yrsCA$106.00k0.012%
€ 68.8k
Aladin Mawani
Independent Director7yrsCA$110.00k0.030%
€ 171.9k
Donna Kingelin
Independent Director8.9yrsCA$115.00k0.0072%
€ 41.3k
Sandra Hanington
Independent Director10.3yrsCA$110.00k0.048%
€ 273.6k
Brent M. Houlden
Independent Director4.6yrsCA$127.00k0.026%
€ 151.3k
Norma Beauchamp
Independent Director5.6yrsCA$100.00k0.0048%
€ 27.5k

8.0yrs

Average Tenure

69yo

Average Age

Experienced Board: 5XE's board of directors are considered experienced (8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 15:41
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Extendicare Inc. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Karine MacIndoeBMO Capital Markets Equity Research
Douglas LoeByron Capital Markets
Douglas LoeCantor Fitzgerald Canada Corporation